Pacira BioSciences, Inc.

NASDAQ (USD): Pacira BioSciences, Inc. (PCRX)

Last Price

14.26

Today's Change

-0.02 (0.14%)

Day's Change

14.20 - 14.83

Trading Volume

1,187,339

Overview

Market Cap

657 Million

Shares Outstanding

46 Million

Avg Volume

1,451,350

Avg Price (50 Days)

16.45

Avg Price (200 Days)

26.08

PE Ratio

10.64

EPS

1.34

Earnings Announcement

31-Oct-2024

Previous Close

14.28

Open

14.45

Day's Range

14.2 - 14.83

Year Range

11.16 - 35.95

Trading Volume

1,187,339

Price Change Highlight

1 Day Change

-0.14%

5 Day Change

-4.17%

1 Month Change

0.49%

3 Month Change

-50.91%

6 Month Change

-50.26%

Ytd Change

-55.44%

1 Year Change

-56.51%

3 Year Change

-75.35%

5 Year Change

-62.36%

10 Year Change

-86.58%

Max Change

103.13%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment